Results 201 to 210 of about 86,450 (250)
Some of the next articles are maybe not open access.
DRUG RESISTANCE IN TUBERCULOSIS
Infectious Disease Clinics of North America, 1997Drug-resistant tuberculosis remains a worldwide problem. New laboratory methods have improved our ability to more rapidly identify resistant strains, but the most effective approach is to prevent the appearance of resistance by appropriate choice of antibiotics and directly-observed therapy.
L M, Parsons +3 more
openaire +2 more sources
Current Opinion in Pulmonary Medicine, 2013
This review discusses the recent evidence on epidemiology, diagnosis, and treatment of drug-resistant and multidrug-resistant (MDR) tuberculosis (TB), an area where solutions for better diagnosis and treatment continually develop.The prevalence of drug resistance has been constantly rising during the recent years.
Pontali E., Matteelli A., Migliori G. B.
openaire +2 more sources
This review discusses the recent evidence on epidemiology, diagnosis, and treatment of drug-resistant and multidrug-resistant (MDR) tuberculosis (TB), an area where solutions for better diagnosis and treatment continually develop.The prevalence of drug resistance has been constantly rising during the recent years.
Pontali E., Matteelli A., Migliori G. B.
openaire +2 more sources
Disease-a-Month, 2006
Eastern Europe, Henan province in China, and certain parts of Russia. 1 The resistance to single drug was reported to range from 2 to 41% (median 9.9%) and to multiple drugs was 0 to 14.4% (prevalence 1.4%) in those who never received prior treatment.
Joel Anthony, Nations +2 more
openaire +2 more sources
Eastern Europe, Henan province in China, and certain parts of Russia. 1 The resistance to single drug was reported to range from 2 to 41% (median 9.9%) and to multiple drugs was 0 to 14.4% (prevalence 1.4%) in those who never received prior treatment.
Joel Anthony, Nations +2 more
openaire +2 more sources
The Lancet, 2001
Abstract: This paper summarizes the presentations of the meeting on drug‐resistant tuberculosis held in London in March of 2001. Multidrug‐resistant tuberculosis (MDR TB) is defined and the causes, risk factors, and recent treatment advances are briefly described. The larger social and economic environment in which MDR TB occurs is discussed.
openaire +4 more sources
Abstract: This paper summarizes the presentations of the meeting on drug‐resistant tuberculosis held in London in March of 2001. Multidrug‐resistant tuberculosis (MDR TB) is defined and the causes, risk factors, and recent treatment advances are briefly described. The larger social and economic environment in which MDR TB occurs is discussed.
openaire +4 more sources
Drug resistant Tuberculosis: A review
Comparative Immunology, Microbiology and Infectious Diseases, 2021Tuberculosis (TB) was announced as a global emergency in 1993. There was an alarming counter attack of TB worldwide. However, when it was known that TB can be cured completely, the general public became ignorant towards the infection. The pathogenic organism Mycobacterium tuberculosis continuously evolved to resist the antagonist drugs. This has led to
Jessy Lallungawi, Khawbung +2 more
openaire +2 more sources
History of Tuberculosis and Drug Resistance
New England Journal of Medicine, 2013n engl j med 368;1 nejm.org january 3, 2013 88 2. Redelmeier DA, Stanbrook MB. Graduated drivers’ licences for seniors: reclaiming one benefit of being young. CMAJ 2012; 184:1123. 3. Stutts J, Wilkins J. Driver licensing policies and practices: gearing up for an aging population.
SOTGIU, Giovanni +2 more
openaire +5 more sources
Current Opinion in Pulmonary Medicine, 2000
There is increasing concern in many countries about the problem of drug-resistant tuberculosis, particularly so because no new classes of drugs have been developed for the treatment of tuberculosis since the 1960s. Although drug resistance is thought to be fairly common in some countries and rare in others, the global extent of this condition is not ...
openaire +2 more sources
There is increasing concern in many countries about the problem of drug-resistant tuberculosis, particularly so because no new classes of drugs have been developed for the treatment of tuberculosis since the 1960s. Although drug resistance is thought to be fairly common in some countries and rare in others, the global extent of this condition is not ...
openaire +2 more sources
Overcoming Drug Resistance for Tuberculosis
Future Microbiology, 2015Despite enormous progress, tuberculosis (TB) is still a major global health problem. Poor patients' adherence to the current treatment leads to the emergence of multidrug resistant (MDR) and extensively drug resistant (XDR) strains. While increased numbers of MDR-TB cases can be ascribed to difficulties in treating TB-HIV coinfected patients, many ...
POCE, Giovanna, BIAVA, Mariangela
openaire +3 more sources
Extensively Drug-resistant Tuberculosis
The American Journal of Medicine, 2008Extensively drug-resistant tuberculosis (XDR-TB) is defined as Mycobacterium tuberculosis infection that is resistant to isoniazid, rifampin, any fluoroquinolone, and any injectable drug (amynoglicosides or polypetides). Although initially described in South Africa, it has emerged as a global threat, and cases have been reported from several countries,
Miguel G, Madariaga +2 more
openaire +4 more sources
Nomenclature of drug-resistant tuberculosis
The Lancet Infectious Diseases, 2013www.thelancet.com/infection Vol 13 November 2013 917 identified studies overlooked by previous reviews. We thought that searching AIDSline was inessential because citations since 2001 are available in Medline. Conference abstracts often present different results to those in published studies and report quality indicators poorly. Google Scholar, because
Zarir F, Udwadia +3 more
openaire +2 more sources